SGRY · XBRL financial data

Surgery Partners financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SGRY's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
General and administrative3721*33402936*36362224*3936
Total operating expenses592634*641677710737*714715716775*745747
Operating income (loss)83101*768561127*62112106110*66102
Other income (expense)11*0(5)1———————
Income tax expense (benefit)36*455121*0(1)614*(1)3
Net income (loss)(5)(1)*(12)(16)(32)(109)*(38)(3)(23)(15)*(36)(15)
Earnings per share, basic USD per share(0.04)(0.01)*(0.10)(0.12)(0.25)(0.86)*(0.30)(0.02)(0.18)(0.12)*(0.28)(0.12)
Earnings per share, diluted USD per share(0.04)(0.01)*(0.10)(0.12)(0.25)(0.86)*(0.30)(0.02)(0.18)(0.12)*(0.28)(0.12)
Weighted average shares, basic millions of shares126126*126126126126*127127127128*128129
Weighted average shares, diluted millions of shares126124*126126126126*127127127128*128129

Balance sheet

CSV

Fiscal quarters (SGRY's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents236196185214222270229250203240182217
Accounts receivable463496494523543579571563579602603617
Inventory6975778182888887929710199
Total current assets8768958961,0131,0361,1191,0751,1051,1021,1511,0831,126
Right-of-use asset245255258267298296278272276289282279
Goodwill4,2454,3264,3984,8064,8155,0685,1265,0995,0925,1955,2055,204
Total assets6,7806,8776,9767,4897,5347,8907,9497,9557,9478,1208,0428,050
Accounts payable149172174174171209165175175209169175
Total current liabilities501523523552575624569573586616582579
Lease liability, non-current241249251258286292273264266280272266
Accumulated deficit(568)(569)(582)(597)(629)(737)(775)(778)(800)(815)(851)(866)
Total stockholders' equity2,0051,9871,9671,9521,8971,7901,7401,7481,7301,7131,6881,671
Total liabilities and equity6,7806,8776,9767,4897,5347,8907,9497,9557,9478,1208,0428,050
Common shares outstanding (cover page) millions of shares126127127127127128128128129129131131

Cash flows

CSV

Fiscal quarters (SGRY's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(5)(1)*(12)(16)(32)(109)*(38)(3)(23)(15)*(36)(15)
Stock-based compensation45*51576*87*3*(2)*64*
Depreciation and amortization2931*34355034*36404060*3939
Net cash from operating activities105*63*4183*65*111*681*84*103*1259*
Purchases of property and equipment19*20*2127*20*22*2323*20*13*1622*
Net cash from investing activities(26)*(58)*(83)(244)*(50)*(112)*(76)2*(46)*(126)*(13)(20)*
Proceeds from issuing common stock—year only———year only——————
Proceeds from long-term debt93*707*1931,103*168*266*214169*128*693*195155*
Repayments of long-term debt76*700*120854*135*171*119180*161*579*194116*
Net cash from financing activities(20)*(45)*32190*(7)*48*30(63)*(84)*59*(56)(5)*
Net change in cash59*(40)*(11)28*8*48*(40)21*(47)*37*(58)34*

Compare with peers

SIC 8062 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8062 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Surgery Partners217not reported59*130.9M 10-QJun 30, 2026
Select Medical Holdings261,42138124.0M 10-QMar 31, 2026
Pediatrix Medical Group312501117*78.1M 10-QSep 30, 2026
Universal Health Services1394,638443*not reported 10-QJun 30, 2026
Tenet Healthcare2,6745,6311,281*79.6M 10-QSep 30, 2026
Encompass Health761,610362*98.1M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.